Tower Research Capital LLC (Trc) Spring Works Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,834 shares of SWTX stock, worth $143,544. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,834
Previous 10,308 62.81%
Holding current value
$143,544
Previous $388,000 68.56%
% of portfolio
0.0%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$32.04 - $42.76 $207,426 - $276,828
-6,474 Reduced 62.81%
3,834 $122,000
Q2 2024

Aug 13, 2024
BUY
$36.06 - $47.62 $268,791 - $354,959
7,454 Added 261.18%
10,308 $388,000
Q1 2024

May 15, 2024
SELL
$36.5 - $52.5 $66,320 - $95,392
-1,817 Reduced 38.9%
2,854 $140,000
Q4 2023

Feb 13, 2024
BUY
$18.94 - $37.24 $65,721 - $129,222
3,470 Added 288.93%
4,671 $170,000
Q3 2023

Nov 14, 2023
SELL
$23.12 - $31.38 $44,413 - $60,280
-1,921 Reduced 61.53%
1,201 $27,000
Q2 2023

Aug 14, 2023
BUY
$23.15 - $32.71 $28,289 - $39,971
1,222 Added 64.32%
3,122 $81,000
Q1 2023

May 09, 2023
SELL
$24.97 - $34.05 $230,872 - $314,826
-9,246 Reduced 82.95%
1,900 $49,000
Q4 2022

Feb 10, 2023
BUY
$21.73 - $28.72 $185,921 - $245,728
8,556 Added 330.35%
11,146 $290,000
Q3 2022

Nov 10, 2022
SELL
$24.1 - $39.66 $276,981 - $455,812
-11,493 Reduced 81.61%
2,590 $74,000
Q2 2022

Aug 15, 2022
BUY
$18.36 - $60.07 $145,503 - $476,054
7,925 Added 128.69%
14,083 $346,000
Q1 2022

May 12, 2022
BUY
$48.97 - $65.46 $25,709 - $34,366
525 Added 9.32%
6,158 $347,000
Q4 2021

Feb 14, 2022
BUY
$53.3 - $75.84 $101,323 - $144,171
1,901 Added 50.94%
5,633 $349,000
Q3 2021

Nov 15, 2021
SELL
$62.66 - $88.26 $45,491 - $64,076
-726 Reduced 16.29%
3,732 $237,000
Q2 2021

Aug 16, 2021
BUY
$67.45 - $85.63 $244,708 - $310,665
3,628 Added 437.11%
4,458 $368,000
Q1 2021

May 17, 2021
SELL
$65.1 - $93.59 $7,942 - $11,417
-122 Reduced 12.82%
830 $61,000
Q4 2020

Feb 16, 2021
SELL
$48.36 - $77.92 $476,974 - $768,524
-9,863 Reduced 91.2%
952 $69,000
Q3 2020

Nov 16, 2020
BUY
$36.14 - $51.99 $305,202 - $439,055
8,445 Added 356.33%
10,815 $516,000
Q2 2020

Aug 13, 2020
BUY
$22.98 - $48.57 $54,462 - $115,110
2,370 New
2,370 $100,000
Q4 2019

Feb 07, 2020
SELL
$17.74 - $39.52 $17,988 - $40,073
-1,014 Closed
0 $0
Q3 2019

Nov 05, 2019
BUY
$18.8 - $27.82 $19,063 - $28,209
1,014 New
1,014 $22,000

Others Institutions Holding SWTX

# of Institutions
238
Shares Held
69.8M
Call Options Held
144K
Put Options Held
257K
View Full List

About SpringWorks Therapeutics, Inc.

SWTX Quotes by TradingView
  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.34B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email